PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 23, 2026Journal of Clinical Medicine0 citationsOpen Access

Awake vs. Sedated Cannulation for Extra-Corporeal Membrane Oxygenation in Patients with COVID-19 Induced Acute Respiratory Distress Syndrome

View Full Paper
OGOri GalanteABAnton BukhinNSNitzan Sagie

Key Points

  • This research aims to evaluate the clinical outcomes of awake versus sedated cannulation for ECMO in patients with COVID-19-related ARDS.
  • Retrospective multicenter study using data from the Israeli ECMO registry.
  • Study group included 24 patients cannulated while awake and spontaneously breathing.
  • Control group comprised 96 patients cannulated after sedation and mechanical ventilation, matched by age, sex, and BMI.
  • Primary outcome measured was six-month survival; secondary outcomes included duration of ECMO and mechanical ventilation.
  • Awake group had a higher six-month survival rate (75%) compared to the sedated group (49%, p = 0.02).
  • Awake cannulation resulted in fewer infectious complications (21% vs. 40%, p < 0.001).
  • Fifteen patients (63%) in the awake group were intubated later.
  • Mean durations on ECMO and in the ICU were similar between both groups.

Abstract

Background: Veno-venous extra-corporeal membrane oxygenation (ECMO) cannulations are mostly performed while patients are heavily sedated and mechanically ventilated. For patients with acute respiratory distress syndrome (ARDS), cannulating for ECMO while awake and spontaneously breathing, as well as treating without sedation and mechanical ventilation, has potential advantages. This study aimed to compare clinical outcomes between patients cannulated for ECMO while awake and patients cannulated while sedated and mechanically ventilated. Methods: A retrospective multicenter study. Data were accessed from the Israeli ECMO registry of patients with COVID-19-induced ARDS treated at eight ECMO centers in Israel. The study group comprised 24 patients who were cannulated while awake and spontaneously breathing. A control group comprised 96 patients who were cannulated after sedation and mechanical ventilation, matched 1:4 by age, sex, and body mass index. The primary outcome was six-month survival. Secondary outcomes were: the duration of ECMO therapy, the duration of invasive mechanical ventilation-free ECMO therapy, and the duration of invasive mechanical ventilation. Results: The mean age was 52 + 11 years; 78% were males. Fifteen patients (63%) in the study group were eventually intubated. The mean durations on ECMO and in the intensive care unit did not differ between the groups. The study group had a higher six-month survival (75% vs. 49%, p = 0.02) and fewer infectious complications such as pneumonia or bacteremia (21% vs. 40%, p < 0.001) compared to the control group. After adjusting for PO2/FiO2 ratio and for the COVID-19 variant, the hazard ratio was 0.45 (C.I 0.19–1.06, p = 0.069). Conclusions: Awake VV-ECMO cannulation in COVID-19-induced ARDS is feasible in selected patients and was associated with higher survival in unadjusted analyses. However, after adjustment for key covariates, this association was attenuated and did not reach statistical significance.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Galante et al. (2026) studied this question.

synapsesocial.com/papers/6973106cc8125b09b0d2012bhttps://doi.org/10.3390/jcm15020876
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Extracorporal Membrane Oxygenation in Nonintubated Patients (Awake ECMO) With COVID-19 Adult Respiratory Distress Syndrome: The Israeli Experience2023 · 11 citations
  2. 2Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome2018 · 2,442 citations
  3. 3Structural differences in the diaphragm of patients following controlled vs assisted and spontaneous mechanical ventilation2019 · 42 citations
  4. 4Early initiation of awake venovenous extracorporeal membrane oxygenation (ECMO) in critical COVID-19 pneumonia: A case reports2021 · 9 citations
  5. 5Optimizing the safety and efficacy of the awake venovenous extracorporeal membrane oxygenation in patients with COVID-19-related ARDS2024 · 6 citations